NCT04766515View on ClinicalTrials.gov

Observational Prospective Study of Immune Checkpoint Inhibitors for Solid Neoplasms

RecruitingOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2025

Conditions

Cancer

Trial Locations (1)

Unknown

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER